HistCite - Trojanowski w/citing papers

Add FileX ?

Use wildcard '*' to add more than one file at a time. For example, if you have file1, file2, etc. all in the same folder or directory; first, locate one of the files with the [Browse...] button. Then alter the file path in the box above to include '*' character (eg. file*). Wildcard '?' to blanket only one character works too.
Note: In Windows you can select multiple files and "drag and drop" them onto HistCite icon or shortcut. The program would start and load those files.

#	Date / Author / Journal	LCS	GCS	LCR	CR
1501	19126 Mazanetz MP, Fischer PM Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases NATURE REVIEWS DRUG DISCOVERY. 2007 JUN; 6 (6): 464-479	46	95	44	164
1502	20297 Zietlow R, Lane EL, Dunnett SB, Rosser AE Human stem cells for CNS repair CELL AND TISSUE RESEARCH. 2008 JAN; 331 (1): 301-322	0	16	29	164
1503	20358 Schapira AHV Mitochondria in the aetiology and pathogenesis of Parkinson's disease LANCET NEUROLOGY. 2008 JAN; 7 (1): 97-109	37	144	35	164
1504	24747 Rozga M, Bal W The Cu(II)/A beta/Human Serum Albumin Model of Control Mechanism for Copper-Related Amyloid Neurotoxicity CHEMICAL RESEARCH IN TOXICOLOGY. 2010 FEB; 23 (2): 298-308	1	2	40	164
1505	25785 van Rooijen BD, Claessens MMAE, Subramaniam V Membrane Interactions of Oligomeric Alpha-Synuclein: Potential Role in Parkinson's Disease CURRENT PROTEIN & PEPTIDE SCIENCE. 2010 AUG; 11 (5): 334-342	0	0	103	164
1506	26226 Ambegaokar SS, Roy B, Jackson GR Neurodegenerative models in Drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis NEUROBIOLOGY OF DISEASE. 2010 OCT; 40 (1): 29-39	0	1	76	164
1507	5562 Price DL, Sisodia SS Mutant genes in familial Alzheimer's disease and transgenic models ANNUAL REVIEW OF NEUROSCIENCE. 1998; 21: 479-505	92	349	27	163
1508	10361 Funahashi S, Takeda K Information processes in the primate prefrontal cortex in relation to working memory processes REVIEWS IN THE NEUROSCIENCES. 2002; 13 (4): 313-345	1	27	27	163
1509	12262 Vila M, Przedborski S Targeting programmed cell death in neurodegenerative diseases NATURE REVIEWS NEUROSCIENCE. 2003 MAY; 4 (5): 365-375	40	153	35	163
1510	17504 Shadrina MI, Slominsky PA Molecular genetics of Parkinson's disease RUSSIAN JOURNAL OF GENETICS. 2006 AUG; 42 (8): 858-871	0	0	38	163
#	Date / Author / Journal	LCS	GCS	LCR	CR
1511	18089 Wang XJ, Robbins J Heart failure and protein quality control CIRCULATION RESEARCH. 2006 DEC 8; 99 (12): 1315-1328	1	36	14	163
1512	18326 Martin LJ Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration REVIEWS IN THE NEUROSCIENCES. 2007; 18 (2): 115-136	6	12	65	163
1513	19124 Neusch C, Bahr M, Schneider-Gold C Glia cells in amyotrophic lateral sclerosis: New clues to understanding an old disease? MUSCLE & NERVE. 2007 JUN; 35 (6): 712-724	8	21	30	163
1514	19303 Korecka JA, Verhaagen J, Hol EM Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease REGENERATIVE MEDICINE. 2007 JUL; 2 (4): 425-446	1	18	37	163
1515	24031 Long-Smith CM, Sullivan AM, Nolan YM The influence of microglia on the pathogenesis of Parkinson's disease PROGRESS IN NEUROBIOLOGY. 2009 NOV; 89 (3): 277-287	5	15	12	163
1516	24382 Lopez-Toledano MA, Faghihi MA, Patel NS, Wahlestedt C Adult Neurogenesis: A Potential Tool for Early Diagnosis in Alzheimer's Disease? JOURNAL OF ALZHEIMERS DISEASE. 2010; 20 (2): 395-408	0	1	23	163
1517	24614 Wisniewski T, Boutajangout A Vaccination as a Therapeutic Approach to Alzheimer's Disease MOUNT SINAI JOURNAL OF MEDICINE. 2010 JAN-FEB; 77 (1): 17-31	3	3	74	163
1518	26636 Fischer A, Sananbenesi F, Mungenast A, Tsai LH Targeting the correct HDAC(s) to treat cognitive disorders TRENDS IN PHARMACOLOGICAL SCIENCES. 2010 DEC; 31 (12): 605-617	0	0	14	163
1519	1327 SILVERMAN JD, KRUGER L CALCITONIN-GENE-RELATED-PEPTIDE-IMMUNOREACTIVE INNERVATION OF THE RAT HEAD WITH EMPHASIS ON SPECIALIZED SENSORY STRUCTURES JOURNAL OF COMPARATIVE NEUROLOGY. 1989 FEB 8; 280 (2): 303-330	7	211	4	162
1520	1827 HANSEN JT, GASH DM FUNCTIONAL-ASPECTS OF MAMMALIAN NEURAL TRANSPLANTATION CRITICAL REVIEWS IN NEUROBIOLOGY. 1991; 6 (2): 79-98	1	4	6	162
#	Date / Author / Journal	LCS	GCS	LCR	CR
1521	2292 BARKER PA, MURPHY RA THE NERVE GROWTH-FACTOR RECEPTOR - A MULTICOMPONENT SYSTEM THAT MEDIATES THE ACTIONS OF THE NEUROTROPHIN FAMILY OF PROTEINS MOLECULAR AND CELLULAR BIOCHEMISTRY. 1992 MAR 4; 110 (1): 1-15	3	63	6	162
1522	2640 DELACOSTE MC, WHITE CL THE ROLE OF CORTICAL CONNECTIVITY IN ALZHEIMERS-DISEASE PATHOGENESIS - A REVIEW AND MODEL SYSTEM NEUROBIOLOGY OF AGING. 1993 JAN-FEB; 14 (1): 1-16	41	153	8	162
1523	4978 Rorke LB, Trojanowski JQ, Lee VMY, Zimmerman RA, Sutton LN, et al. Primitive neuroectodermal tumors of the central nervous system BRAIN PATHOLOGY. 1997 APR; 7 (2): 765-784	56	56	28	162
1524	6143 Cummings JL, Vinters HV, Cole GM, Khachaturian ZS Alzheimer's disease - Etiologies, pathophysiology, cognitive reserve, and treatment opportunities NEUROLOGY. 1998 JUL; 51 (1): S2-S17	29	160	5	162
1525	7574 Flint J The genetic basis of cognition BRAIN. 1999 NOV; 122: 2015-2031	2	35	5	162
1526	9048 Price DL, Wong PC, Markowska AL, Thinakaran G, Lee MK, et al. The value of transgenic models for the study of neurodegenerative diseases NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION. 2001; : 67-86	0	0	35	162
1527	12032 Levinson DF Molecular genetics of schizophrenia: a review of the recent literature CURRENT OPINION IN PSYCHIATRY. 2003 MAR; 16 (2): 157-170	2	16	3	162
1528	13338 Bartzokis G Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders NEUROBIOLOGY OF AGING. 2004 JAN; 25 (1): 49-62	6	49	27	162
1529	13401 Mignot C, Boespflug-Tanguy O, Gelot A, Dautigny A, Pham-Dinh D, et al. Alexander disease: putative mechanisms of an astrocytic encephalopathy CELLULAR AND MOLECULAR LIFE SCIENCES. 2004 FEB; 61 (3): 369-385	7	34	15	162
1530	13457 Zimmerman MC, Davisson RL Redox signaling in central neural regulation of cardiovascular function PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY. 2004 FEB-APR; 84 (2-3): 125-149	1	43	3	162
#	Date / Author / Journal	LCS	GCS	LCR	CR
1531	14888 Gupta VB, Anitha S, Hegde ML, Zecca L, Garruto RM, et al. Aluminium in Alzheimer's disease: are we still at a crossroad? CELLULAR AND MOLECULAR LIFE SCIENCES. 2005 JAN; 62 (2): 143-158	17	71	19	162
1532	15765 Shaw PJ Molecular and cellular pathways of neurodegeneration in motor neurone disease JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2005 AUG; 76 (8): 1046-1057	23	88	38	162
1533	16654 Inoue K The function of microglia through purinergic receptors: Neuropathic pain and cytokine release PHARMACOLOGY & THERAPEUTICS. 2006 JAN; 109 (1-2): 210-226	0	84	2	162
1534	17481 Reddy PH, McWeeney S Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models NEUROBIOLOGY OF AGING. 2006 AUG; 27 (8): 1060-1077	8	24	48	162
1535	18149 de Jong D, Kremer BPH, Olde Rikkert MGM, Verbeek MM Current state and future directions of neurochemical biomarkers for Alzheimer's disease CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2007; 45 (11): 1421-1434	9	16	68	162
1536	18346 Jellinger KA The enigma of mixed dementia ALZHEIMERS & DEMENTIA. 2007 JAN; 3 (1): 40-53	5	11	23	162
1537	20149 Bush AI Drug Development Based on the Metals Hypothesis of Alzheimer's Disease JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (2): 223-240	4	30	24	162
1538	20535 Corcia P, Praline J, Vourc'h P, Andres C Genetics of motor neuron disorders REVUE NEUROLOGIQUE. 2008 FEB; 164 (2): 115-130	1	2	16	162
1539	20650 Capitanio JP, Emborg ME Contributions of non-human primates to neuroscience research LANCET. 2008 MAR-APR; 371 (9618): 1126-1135	2	13	18	162
1540	21117 Strnad P, Stumptner C, Zatloukal K, Denk H Intermediate filament cytoskeleton of the liver in health and disease HISTOCHEMISTRY AND CELL BIOLOGY. 2008 JUN; 129 (6): 735-749	2	16	15	162
#	Date / Author / Journal	LCS	GCS	LCR	CR
1541	22645 Morris AM, Watzky MA, Finke RG Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2009 MAR; 1794 (3): 375-397	5	31	19	162
1542	22803 Johnsen J, Kogner P, Albihn A, Henriksson M Embryonal neural tumours and cell death APOPTOSIS. 2009 APR; 14 (4): 424-438	5	11	12	162
1543	24269 Anzenbacher P, Lubal P, Bucek P, Palacios MA, Kozelkova ME A practical approach to optical cross-reactive sensor arrays CHEMICAL SOCIETY REVIEWS. 2010; 39 (10): 3954-3979	0	0	2	162
1544	24849 Tarawneh R, Galvin JE Potential Future Neuroprotective Therapies for Neurodegenerative Disorders and Stroke CLINICS IN GERIATRIC MEDICINE. 2010 FEB 10; 26 (1): 125-+	1	1	22	162
1545	26560 Wisniewski T, Goni F Immunomodulation for prion and prion-related diseases EXPERT REVIEW OF VACCINES. 2010 DEC; 9 (12): 1441-1452	0	0	18	162
1546	684 DAVIDOFF MS IMMUNOCYTOCHEMISTRY - POSSIBILITIES FOR DETECTION OF DIFFERENT TISSUE ANTIGENS AND ESTABLISHMENT OF THE FUNCTIONAL-ROLE OF CELLS ACTA HISTOCHEMICA. 1986; : 175-193	0	0	1	161
1547	8126 Shadlen MF, Larson EB, Yukawa M The epidemiology of Alzheimer's disease and vascular dementia in Japanese and African-American populations: the search for etiological clues NEUROBIOLOGY OF AGING. 2000 MAR-APR; 21 (2): 171-181	3	10	9	161
1548	9304 Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, et al. From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B- BIOLOGICAL SCIENCES. 2001 FEB 28; 356 (1406): 213-227	28	34	105	161
1549	10651 Arenas E Stem cells in the treatment of Parkinson's disease BRAIN RESEARCH BULLETIN. 2002 APR; 57 (6): 795-808	21	73	21	161
1550	11344 Di Monte DA, Lavasani M, Manning-Bog AB Environmental factors in Parkinson's disease NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 487-502	25	86	8	161
#	Date / Author / Journal	LCS	GCS	LCR	CR
1551	11832 Ermonval M, Mouillet-Richard S, Codogno P, Kellermann O, Botti J Evolving views in prion glycosylation: functional and pathological implications BIOCHIMIE. 2003 JAN-FEB; 85 (1-2): 33-45	1	23	17	161
1552	11966 Petrella JR, Coleman RE, Doraiswamy PM Neuroimaging and early diagnosis of Alzheimer disease: A look to the future RADIOLOGY. 2003 FEB; 226 (2): 315-336	18	102	10	161
1553	12433 Stein DG, Hoffman SW Concepts of CNS plasticity in the context of brain damage and repair JOURNAL OF HEAD TRAUMA REHABILITATION. 2003 JUL-AUG; 18 (4): 317-341	0	20	9	161
1554	13160 Strehl R, Schumacher K, Minuth WW The current state of engineering tissues and organ parts ETHICAL, LEGAL, AND SOCIAL ISSUES IN ORGAN TRANSPLANTATION. 2004; : 405-422	0	0	2	161
1555	14382 Teismann P, Schulz JB Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 149-161	22	115	14	161
1556	14512 Correale J, Villa A The neuroprotective role of inflammation in nervous system injuries JOURNAL OF NEUROLOGY. 2004 NOV; 251 (11): 1304-1316	10	46	4	161
1557	14773 Arendt T Alzheimer's disease as a disorder of dynamic brain self-organization DEVELOPMENT, DYNAMICS AND PATHOLOGY OF NEURONAL NETWORKS: FROM MOLECULES TO FUNCTIONAL CIRCUITS. 2005; 147: 355-378	1	11	34	161
1558	15077 Inoue K PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2 NEUROGENETICS. 2005 FEB; 6 (1): 1-16	3	54	1	161
1559	15231 Smeyne RJ, Jackson-Lewis V The MPTP model of Parkinson's disease MOLECULAR BRAIN RESEARCH. 2005 MAR 24; 134 (1): 57-66	7	73	20	161
1560	19230 Gallo JM, Noble W, Martin TR RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies CELLULAR AND MOLECULAR LIFE SCIENCES. 2007 JUL; 64 (13): 1701-1714	5	8	128	161
#	Date / Author / Journal	LCS	GCS	LCR	CR
1561	20201 Cassel JC, Mathis C, Majchrzak M, Moreau PH, Dalrymple-Alford JC Coexisting cholinergic and parahippocampal degeneration: A key to memory loss in dementia and a challenge for transgenic models? NEURODEGENERATIVE DISEASES. 2008; 5 (5): 304-317	1	7	41	161
1562	20790 Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, et al. Biochemistry of Tau in Alzheimer's disease and related neurological disorders EXPERT REVIEW OF PROTEOMICS. 2008 APR; 5 (2): 207-224	15	18	82	161
1563	22112 Caughey B, Baron GS, Chesebro B, Jeffrey M Getting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions ANNUAL REVIEW OF BIOCHEMISTRY. 2009; 78: 177-204	3	30	8	161
1564	25546 Dawson TM, Ko HS, Dawson VL Genetic Animal Models of Parkinson's Disease NEURON. 2010 JUN 10; 66 (5): 646-661	3	5	89	161
1565	26170 Cho DH, Nakamura T, Lipton SA Mitochondrial dynamics in cell death and neurodegeneration CELLULAR AND MOLECULAR LIFE SCIENCES. 2010 OCT; 67 (20): 3435-3447	0	1	8	161
1566	182 STREITFELD BD THE FIBER-CONNECTIONS OF THE TEMPORAL-LOBE WITH EMPHASIS ON THE RHESUS- MONKEY INTERNATIONAL JOURNAL OF NEUROSCIENCE. 1980; 11 (1): 51-71	4	22	6	160
1567	3211 FILLER AG AXONAL-TRANSPORT AND MR-IMAGING - PROSPECTS FOR CONTRAST AGENT DEVELOPMENT JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING. 1994 MAY-JUN; 4 (3): 259-267	0	10	12	160
1568	8380 Woerly S Restorative surgery of the central nervous system by means of tissue engineering using NeuroGel implants NEUROSURGICAL REVIEW. 2000 JUN; 23 (2): 59-77	0	27	14	160
1569	10507 Tentori L, Portarena I, Graziani G Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors PHARMACOLOGICAL RESEARCH. 2002 FEB; 45 (2): 73-85	0	83	3	160
1570	10971 Sarvari M, Fesus L, Nemes Z Transglutaminase-mediated crosslinking of neural proteins in Alzheimer's disease and other primary dementias DRUG DEVELOPMENT RESEARCH. 2002 JUL; 56 (3): 458-472	1	12	36	160
#	Date / Author / Journal	LCS	GCS	LCR	CR
1571	11923 Lahiri DK, Farlow MR, Sambamurti K, Greig NH, Giacobini E, et al. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease CURRENT DRUG TARGETS. 2003 FEB; 4 (2): 97-112	7	86	25	160
1572	13834 Petit D, Gagnon JF, Fantini ML, Ferini-Strambi L, Montplaisir J Sleep and quantitative EEG in neurodegenerative disorders JOURNAL OF PSYCHOSOMATIC RESEARCH. 2004 MAY; 56 (5): 487-496	9	48	9	160
1573	15663 Kuret J, Congdon EE, Li GB, Yin HH, Yu X, et al. Evaluating triggers and enhancers of tau fibrillization MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 141-155	19	25	82	160
1574	17599 Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L Mitochondrial dysfunction, oxidative stress and neurodegeneration JOURNAL OF ALZHEIMERS DISEASE. 2006 SEP; 10 (1): 59-73	9	61	24	160
1575	17871 Chevalier-Larsen E, Holzbaur ELF Axonal transport and neurodegenerative disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 NOV-DEC; 1762 (11-12): 1094-1108	24	87	25	160
1576	20993 Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia TRENDS IN NEUROSCIENCES. 2008 MAY; 31 (5): 234-242	7	107	10	160
1577	22491 Jellinger KA Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 101-110	13	20	66	160
1578	24495 Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, et al. Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson's Disease NEURODEGENERATIVE DISEASES. 2010; 7 (5): 300-318	0	0	16	160
1579	25306 Onvani S, Etame AB, Smith CA, Rutka JT Genetics of medulloblastoma: clues for novel therapies EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 MAY; 10 (5): 811-823	0	0	28	160
1580	26543 Gozes I Tau Pathology and Future Therapeutics CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 685-696	1	1	78	160
#	Date / Author / Journal	LCS	GCS	LCR	CR
1581	1441 JOLLES PR, CHAPMAN PR, ALAVI A PET, CT, AND MRI IN THE EVALUATION OF NEUROPSYCHIATRIC DISORDERS - CURRENT APPLICATIONS JOURNAL OF NUCLEAR MEDICINE. 1989 OCT; 30 (10): 1589-1606	1	44	1	159
1582	1860 MENEI P, POUPLARDBARTHELAIX A, GUY G COMPLICATIONS AND BIOLOGICAL RISKS OF NEURAL TRANSPLANTATIONS NEUROCHIRURGIE. 1991; 37 (6): 364-376	0	1	8	159
1583	9761 Colcher A, Simuni T Other Parkinson syndromes NEUROLOGIC CLINICS. 2001 AUG; 19 (3): 629-+	1	4	6	159
1584	12422 Bayir H, Kochanek PM, Clark RSB Traumatic brain injury in infants and children - Mechanisms of secondary damage and treatment in the intensive care unit CRITICAL CARE CLINICS. 2003 JUL; 19 (3): 529-+	2	25	11	159
1585	14557 Ulloa-Aguirre A, Janovick JA, Brothers SP, Conn PM Pharmacologic rescue of conformationally-defective proteins: Implications for the treatment of human disease TRAFFIC. 2004 NOV; 5 (11): 821-837	3	127	8	159
1586	14651 Walter BL, Vitek JL Surgical treatment for Parkinson's disease LANCET NEUROLOGY. 2004 DEC; 3 (12): 719-728	10	53	7	159
1587	16496 Gong CX, Liu F, Grundke-Iqbal I, Iqbal K Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: A therapeutic target JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 31825	0	16	98	159
1588	17338 Hamaguchi T, Ono K, Yamada M Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer's disease CELLULAR AND MOLECULAR LIFE SCIENCES. 2006 JUL; 63 (13): 1538-1552	2	17	17	159
1589	19536 Curtis MA, Faull RLM, Eriksson PS The effect of neurodegenerative diseases on the subventricular zone NATURE REVIEWS NEUROSCIENCE. 2007 SEP; 8 (9): 712-723	3	33	9	159
1590	19740 Thomas B, Beal MF Parkinson's disease HUMAN MOLECULAR GENETICS. 2007 OCT 15; 16: R183-R194	62	148	71	159
#	Date / Author / Journal	LCS	GCS	LCR	CR
1591	20049 Yankner BA, Lu T, Loerch P The aging brain ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. 2008; 3: 41-66	18	65	15	159
1592	21266 Tumani H, Teunissen C, Sossmuth S, Otto M, Ludolph AC, et al. Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2008 JUL; 8 (4): 479-494	2	13	43	159
1593	21663 Aluise CD, Sowell RA, Butterfield DA Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2008 OCT; 1782 (10): 549-558	2	5	43	159
1594	21697 Thal DR, Griffin WST, Braak H Parenchymal and vascular A beta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 OCT; 12 (5B): 1848-1862	3	14	28	159
1595	22238 Koudinov A, Kezlya E, Koudinova N, Berezov T Amyloid-beta, Tau Protein, and Oxidative Changes as a Physiological Compensatory Mechanism to Maintain CNS Plasticity under Alzheimer's Disease and Other Neurodegenerative Conditions JOURNAL OF ALZHEIMERS DISEASE. 2009; 18 (2): 381-400	0	5	15	159
1596	22413 Blazer LL, Neubig RR Small Molecule Protein-Protein Interaction Inhibitors as CNS Therapeutic Agents: Current Progress and Future Hurdles NEUROPSYCHOPHARMACOLOGY. 2009 JAN; 34 (1): 126-141	4	28	26	159
1597	22863 Gispen-De Wied CC, Kritsidima M, Elferink AJA The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES) JOURNAL OF NUTRITION HEALTH & AGING. 2009 APR; 13 (4): 376-387	1	4	30	159
1598	23303 Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, et al. Cognitive Impairment and Dementia in Patients with Parkinson Disease CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2009 JUL; 9 (10): 903-912	1	2	43	159
1599	24529 Orlova KA, Crino PB The tuberous sclerosis complex YEAR IN NEUROLOGY 2. 2010; 1184: 87-105	0	6	13	159
1600	24990 Blennow K, Hampel H, Weiner M, Zetterberg H Cerebrospinal fluid and plasma biomarkers in Alzheimer disease NATURE REVIEWS NEUROLOGY. 2010 MAR; 6 (3): 131-144	19	29	56	159

Date / Author / Journal

LCS

GCS

LCR

1501

19126 Mazanetz MP, Fischer PM

Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases

NATURE REVIEWS DRUG DISCOVERY. 2007 JUN; 6 (6): 464-479

164

1502

20297 Zietlow R, Lane EL, Dunnett SB, Rosser AE

Human stem cells for CNS repair

CELL AND TISSUE RESEARCH. 2008 JAN; 331 (1): 301-322

164

1503

20358 Schapira AHV

Mitochondria in the aetiology and pathogenesis of Parkinson's disease

LANCET NEUROLOGY. 2008 JAN; 7 (1): 97-109

144

164

1504

24747 Rozga M, Bal W

The Cu(II)/A beta/Human Serum Albumin Model of Control Mechanism for Copper-Related Amyloid Neurotoxicity

CHEMICAL RESEARCH IN TOXICOLOGY. 2010 FEB; 23 (2): 298-308

164

1505

25785 van Rooijen BD, Claessens MMAE, Subramaniam V

Membrane Interactions of Oligomeric Alpha-Synuclein: Potential Role in Parkinson's Disease

CURRENT PROTEIN & PEPTIDE SCIENCE. 2010 AUG; 11 (5): 334-342

103

164

1506

26226 Ambegaokar SS, Roy B, Jackson GR

Neurodegenerative models in Drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis

NEUROBIOLOGY OF DISEASE. 2010 OCT; 40 (1): 29-39

164

1507

5562 Price DL, Sisodia SS

Mutant genes in familial Alzheimer's disease and transgenic models

ANNUAL REVIEW OF NEUROSCIENCE. 1998; 21: 479-505

349

163

1508

10361 Funahashi S, Takeda K

Information processes in the primate prefrontal cortex in relation to working memory processes

REVIEWS IN THE NEUROSCIENCES. 2002; 13 (4): 313-345

163

1509

12262 Vila M, Przedborski S

Targeting programmed cell death in neurodegenerative diseases

NATURE REVIEWS NEUROSCIENCE. 2003 MAY; 4 (5): 365-375

153

163

1510

17504 Shadrina MI, Slominsky PA

Molecular genetics of Parkinson's disease

RUSSIAN JOURNAL OF GENETICS. 2006 AUG; 42 (8): 858-871

163

Date / Author / Journal

LCS

GCS

LCR

1511

18089 Wang XJ, Robbins J

Heart failure and protein quality control

CIRCULATION RESEARCH. 2006 DEC 8; 99 (12): 1315-1328

163

1512

18326 Martin LJ

Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration

REVIEWS IN THE NEUROSCIENCES. 2007; 18 (2): 115-136

163

1513

19124 Neusch C, Bahr M, Schneider-Gold C

Glia cells in amyotrophic lateral sclerosis: New clues to understanding an old disease?

MUSCLE & NERVE. 2007 JUN; 35 (6): 712-724

163

1514

19303 Korecka JA, Verhaagen J, Hol EM

Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease

REGENERATIVE MEDICINE. 2007 JUL; 2 (4): 425-446

163

1515

24031 Long-Smith CM, Sullivan AM, Nolan YM

The influence of microglia on the pathogenesis of Parkinson's disease

PROGRESS IN NEUROBIOLOGY. 2009 NOV; 89 (3): 277-287

163

1516

24382 Lopez-Toledano MA, Faghihi MA, Patel NS, Wahlestedt C

Adult Neurogenesis: A Potential Tool for Early Diagnosis in Alzheimer's Disease?

JOURNAL OF ALZHEIMERS DISEASE. 2010; 20 (2): 395-408

163

1517

24614 Wisniewski T, Boutajangout A

Vaccination as a Therapeutic Approach to Alzheimer's Disease

MOUNT SINAI JOURNAL OF MEDICINE. 2010 JAN-FEB; 77 (1): 17-31

163

1518

26636 Fischer A, Sananbenesi F, Mungenast A, Tsai LH

Targeting the correct HDAC(s) to treat cognitive disorders

TRENDS IN PHARMACOLOGICAL SCIENCES. 2010 DEC; 31 (12): 605-617

163

1519

1327 SILVERMAN JD, KRUGER L

CALCITONIN-GENE-RELATED-PEPTIDE-IMMUNOREACTIVE INNERVATION OF THE RAT HEAD WITH EMPHASIS ON SPECIALIZED SENSORY STRUCTURES

JOURNAL OF COMPARATIVE NEUROLOGY. 1989 FEB 8; 280 (2): 303-330

211

162

1520

1827 HANSEN JT, GASH DM

FUNCTIONAL-ASPECTS OF MAMMALIAN NEURAL TRANSPLANTATION

CRITICAL REVIEWS IN NEUROBIOLOGY. 1991; 6 (2): 79-98

162

Date / Author / Journal

LCS

GCS

LCR

1521

2292 BARKER PA, MURPHY RA

THE NERVE GROWTH-FACTOR RECEPTOR - A MULTICOMPONENT SYSTEM THAT MEDIATES THE ACTIONS OF THE NEUROTROPHIN FAMILY OF PROTEINS

MOLECULAR AND CELLULAR BIOCHEMISTRY. 1992 MAR 4; 110 (1): 1-15

162

1522

2640 DELACOSTE MC, WHITE CL

THE ROLE OF CORTICAL CONNECTIVITY IN ALZHEIMERS-DISEASE PATHOGENESIS - A REVIEW AND MODEL SYSTEM

NEUROBIOLOGY OF AGING. 1993 JAN-FEB; 14 (1): 1-16

153

162

1523

4978 Rorke LB, Trojanowski JQ, Lee VMY, Zimmerman RA, Sutton LN, et al.

Primitive neuroectodermal tumors of the central nervous system

BRAIN PATHOLOGY. 1997 APR; 7 (2): 765-784

162

1524

6143 Cummings JL, Vinters HV, Cole GM, Khachaturian ZS

Alzheimer's disease - Etiologies, pathophysiology, cognitive reserve, and treatment opportunities

NEUROLOGY. 1998 JUL; 51 (1): S2-S17

160

162

1525

7574 Flint J

The genetic basis of cognition

BRAIN. 1999 NOV; 122: 2015-2031

162

1526

9048 Price DL, Wong PC, Markowska AL, Thinakaran G, Lee MK, et al.

The value of transgenic models for the study of neurodegenerative diseases

NEURODEGENERATIVE DISORDERS: LOSS OF FUNCTION THROUGH GAIN OF FUNCTION. 2001; : 67-86

162

1527

12032 Levinson DF

Molecular genetics of schizophrenia: a review of the recent literature

CURRENT OPINION IN PSYCHIATRY. 2003 MAR; 16 (2): 157-170

162

1528

13338 Bartzokis G

Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders

NEUROBIOLOGY OF AGING. 2004 JAN; 25 (1): 49-62

162

1529

13401 Mignot C, Boespflug-Tanguy O, Gelot A, Dautigny A, Pham-Dinh D, et al.

Alexander disease: putative mechanisms of an astrocytic encephalopathy

CELLULAR AND MOLECULAR LIFE SCIENCES. 2004 FEB; 61 (3): 369-385

162

1530

13457 Zimmerman MC, Davisson RL

Redox signaling in central neural regulation of cardiovascular function

PROGRESS IN BIOPHYSICS & MOLECULAR BIOLOGY. 2004 FEB-APR; 84 (2-3): 125-149

162

Date / Author / Journal

LCS

GCS

LCR

1531

14888 Gupta VB, Anitha S, Hegde ML, Zecca L, Garruto RM, et al.

Aluminium in Alzheimer's disease: are we still at a crossroad?

CELLULAR AND MOLECULAR LIFE SCIENCES. 2005 JAN; 62 (2): 143-158

162

1532

15765 Shaw PJ

Molecular and cellular pathways of neurodegeneration in motor neurone disease

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2005 AUG; 76 (8): 1046-1057

162

1533

16654 Inoue K

The function of microglia through purinergic receptors: Neuropathic pain and cytokine release

PHARMACOLOGY & THERAPEUTICS. 2006 JAN; 109 (1-2): 210-226

162

1534

17481 Reddy PH, McWeeney S

Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models

NEUROBIOLOGY OF AGING. 2006 AUG; 27 (8): 1060-1077

162

1535

18149 de Jong D, Kremer BPH, Olde Rikkert MGM, Verbeek MM

Current state and future directions of neurochemical biomarkers for Alzheimer's disease

CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2007; 45 (11): 1421-1434

162

1536

18346 Jellinger KA

The enigma of mixed dementia

ALZHEIMERS & DEMENTIA. 2007 JAN; 3 (1): 40-53

162

1537

20149 Bush AI

Drug Development Based on the Metals Hypothesis of Alzheimer's Disease

JOURNAL OF ALZHEIMERS DISEASE. 2008; 15 (2): 223-240

162

1538

20535 Corcia P, Praline J, Vourc'h P, Andres C

Genetics of motor neuron disorders

REVUE NEUROLOGIQUE. 2008 FEB; 164 (2): 115-130

162

1539

20650 Capitanio JP, Emborg ME

Contributions of non-human primates to neuroscience research

LANCET. 2008 MAR-APR; 371 (9618): 1126-1135

162

1540

21117 Strnad P, Stumptner C, Zatloukal K, Denk H

Intermediate filament cytoskeleton of the liver in health and disease

HISTOCHEMISTRY AND CELL BIOLOGY. 2008 JUN; 129 (6): 735-749

162

Date / Author / Journal

LCS

GCS

LCR

1541

22645 Morris AM, Watzky MA, Finke RG

Protein aggregation kinetics, mechanism, and curve-fitting: A review of the literature

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS. 2009 MAR; 1794 (3): 375-397

162

1542

22803 Johnsen J, Kogner P, Albihn A, Henriksson M

Embryonal neural tumours and cell death

APOPTOSIS. 2009 APR; 14 (4): 424-438

162

1543

24269 Anzenbacher P, Lubal P, Bucek P, Palacios MA, Kozelkova ME

A practical approach to optical cross-reactive sensor arrays

CHEMICAL SOCIETY REVIEWS. 2010; 39 (10): 3954-3979

162

1544

24849 Tarawneh R, Galvin JE

Potential Future Neuroprotective Therapies for Neurodegenerative Disorders and Stroke

CLINICS IN GERIATRIC MEDICINE. 2010 FEB 10; 26 (1): 125-+

162

1545

26560 Wisniewski T, Goni F

Immunomodulation for prion and prion-related diseases

EXPERT REVIEW OF VACCINES. 2010 DEC; 9 (12): 1441-1452

162

1546

684 DAVIDOFF MS

IMMUNOCYTOCHEMISTRY - POSSIBILITIES FOR DETECTION OF DIFFERENT TISSUE ANTIGENS AND ESTABLISHMENT OF THE FUNCTIONAL-ROLE OF CELLS

ACTA HISTOCHEMICA. 1986; : 175-193

161

1547

8126 Shadlen MF, Larson EB, Yukawa M

The epidemiology of Alzheimer's disease and vascular dementia in Japanese and African-American populations: the search for etiological clues

NEUROBIOLOGY OF AGING. 2000 MAR-APR; 21 (2): 171-181

161

1548

9304 Goedert M, Spillantini MG, Serpell LC, Berriman J, Smith MJ, et al.

From genetics to pathology: tau and alpha-synuclein assemblies in neurodegenerative diseases

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B- BIOLOGICAL SCIENCES. 2001 FEB 28; 356 (1406): 213-227

105

161

1549

10651 Arenas E

Stem cells in the treatment of Parkinson's disease

BRAIN RESEARCH BULLETIN. 2002 APR; 57 (6): 795-808

161

1550

11344 Di Monte DA, Lavasani M, Manning-Bog AB

Environmental factors in Parkinson's disease

NEUROTOXICOLOGY. 2002 OCT; 23 (4-5): 487-502

161

Date / Author / Journal

LCS

GCS

LCR

1551

11832 Ermonval M, Mouillet-Richard S, Codogno P, Kellermann O, Botti J

Evolving views in prion glycosylation: functional and pathological implications

BIOCHIMIE. 2003 JAN-FEB; 85 (1-2): 33-45

161

1552

11966 Petrella JR, Coleman RE, Doraiswamy PM

Neuroimaging and early diagnosis of Alzheimer disease: A look to the future

RADIOLOGY. 2003 FEB; 226 (2): 315-336

102

161

1553

12433 Stein DG, Hoffman SW

Concepts of CNS plasticity in the context of brain damage and repair

JOURNAL OF HEAD TRAUMA REHABILITATION. 2003 JUL-AUG; 18 (4): 317-341

161

1554

13160 Strehl R, Schumacher K, Minuth WW

The current state of engineering tissues and organ parts

ETHICAL, LEGAL, AND SOCIAL ISSUES IN ORGAN TRANSPLANTATION. 2004; : 405-422

161

1555

14382 Teismann P, Schulz JB

Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation

CELL AND TISSUE RESEARCH. 2004 OCT; 318 (1): 149-161

115

161

1556

14512 Correale J, Villa A

The neuroprotective role of inflammation in nervous system injuries

JOURNAL OF NEUROLOGY. 2004 NOV; 251 (11): 1304-1316

161

1557

14773 Arendt T

Alzheimer's disease as a disorder of dynamic brain self-organization

DEVELOPMENT, DYNAMICS AND PATHOLOGY OF NEURONAL NETWORKS: FROM MOLECULES TO FUNCTIONAL CIRCUITS. 2005; 147: 355-378

161

1558

15077 Inoue K

NEUROGENETICS. 2005 FEB; 6 (1): 1-16

161

1559

15231 Smeyne RJ, Jackson-Lewis V

The MPTP model of Parkinson's disease

MOLECULAR BRAIN RESEARCH. 2005 MAR 24; 134 (1): 57-66

161

1560

19230 Gallo JM, Noble W, Martin TR

RNA and protein-dependent mechanisms in tauopathies: consequences for therapeutic strategies

CELLULAR AND MOLECULAR LIFE SCIENCES. 2007 JUL; 64 (13): 1701-1714

128

161

Date / Author / Journal

LCS

GCS

LCR

1561

20201 Cassel JC, Mathis C, Majchrzak M, Moreau PH, Dalrymple-Alford JC

Coexisting cholinergic and parahippocampal degeneration: A key to memory loss in dementia and a challenge for transgenic models?

NEURODEGENERATIVE DISEASES. 2008; 5 (5): 304-317

161

1562

20790 Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, et al.

Biochemistry of Tau in Alzheimer's disease and related neurological disorders

EXPERT REVIEW OF PROTEOMICS. 2008 APR; 5 (2): 207-224

161

1563

22112 Caughey B, Baron GS, Chesebro B, Jeffrey M

Getting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions

ANNUAL REVIEW OF BIOCHEMISTRY. 2009; 78: 177-204

161

1564

25546 Dawson TM, Ko HS, Dawson VL

Genetic Animal Models of Parkinson's Disease

NEURON. 2010 JUN 10; 66 (5): 646-661

161

1565

26170 Cho DH, Nakamura T, Lipton SA

Mitochondrial dynamics in cell death and neurodegeneration

CELLULAR AND MOLECULAR LIFE SCIENCES. 2010 OCT; 67 (20): 3435-3447

161

1566

182 STREITFELD BD

THE FIBER-CONNECTIONS OF THE TEMPORAL-LOBE WITH EMPHASIS ON THE RHESUS- MONKEY

INTERNATIONAL JOURNAL OF NEUROSCIENCE. 1980; 11 (1): 51-71

160

1567

3211 FILLER AG

AXONAL-TRANSPORT AND MR-IMAGING - PROSPECTS FOR CONTRAST AGENT DEVELOPMENT

JMRI-JOURNAL OF MAGNETIC RESONANCE IMAGING. 1994 MAY-JUN; 4 (3): 259-267

160

1568

8380 Woerly S

Restorative surgery of the central nervous system by means of tissue engineering using NeuroGel implants

NEUROSURGICAL REVIEW. 2000 JUN; 23 (2): 59-77

160

1569

10507 Tentori L, Portarena I, Graziani G

Potential clinical applications of poly(ADP-ribose) polymerase (PARP) inhibitors

PHARMACOLOGICAL RESEARCH. 2002 FEB; 45 (2): 73-85

160

1570

10971 Sarvari M, Fesus L, Nemes Z

Transglutaminase-mediated crosslinking of neural proteins in Alzheimer's disease and other primary dementias

DRUG DEVELOPMENT RESEARCH. 2002 JUL; 56 (3): 458-472

160

Date / Author / Journal

LCS

GCS

LCR

1571

11923 Lahiri DK, Farlow MR, Sambamurti K, Greig NH, Giacobini E, et al.

A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease

CURRENT DRUG TARGETS. 2003 FEB; 4 (2): 97-112

160

1572

13834 Petit D, Gagnon JF, Fantini ML, Ferini-Strambi L, Montplaisir J

Sleep and quantitative EEG in neurodegenerative disorders

JOURNAL OF PSYCHOSOMATIC RESEARCH. 2004 MAY; 56 (5): 487-496

160

1573

15663 Kuret J, Congdon EE, Li GB, Yin HH, Yu X, et al.

Evaluating triggers and enhancers of tau fibrillization

MICROSCOPY RESEARCH AND TECHNIQUE. 2005 JUL; 67 (3-4): 141-155

160

1574

17599 Mancuso M, Coppede F, Migliore L, Siciliano G, Murri L

Mitochondrial dysfunction, oxidative stress and neurodegeneration

JOURNAL OF ALZHEIMERS DISEASE. 2006 SEP; 10 (1): 59-73

160

1575

17871 Chevalier-Larsen E, Holzbaur ELF

Axonal transport and neurodegenerative disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2006 NOV-DEC; 1762 (11-12): 1094-1108

160

1576

20993 Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, et al.

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

TRENDS IN NEUROSCIENCES. 2008 MAY; 31 (5): 234-242

107

160

1577

22491 Jellinger KA

Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp?

ACTA NEUROPATHOLOGICA. 2009 FEB; 117 (2): 101-110

160

1578

24495 Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, et al.

Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson's Disease

NEURODEGENERATIVE DISEASES. 2010; 7 (5): 300-318

160

1579

25306 Onvani S, Etame AB, Smith CA, Rutka JT

Genetics of medulloblastoma: clues for novel therapies

EXPERT REVIEW OF NEUROTHERAPEUTICS. 2010 MAY; 10 (5): 811-823

160

1580

26543 Gozes I

Tau Pathology and Future Therapeutics

CURRENT ALZHEIMER RESEARCH. 2010 DEC; 7 (8): 685-696

160

Date / Author / Journal

LCS

GCS

LCR

1581

1441 JOLLES PR, CHAPMAN PR, ALAVI A

PET, CT, AND MRI IN THE EVALUATION OF NEUROPSYCHIATRIC DISORDERS - CURRENT APPLICATIONS

JOURNAL OF NUCLEAR MEDICINE. 1989 OCT; 30 (10): 1589-1606

159

1582

1860 MENEI P, POUPLARDBARTHELAIX A, GUY G

COMPLICATIONS AND BIOLOGICAL RISKS OF NEURAL TRANSPLANTATIONS

NEUROCHIRURGIE. 1991; 37 (6): 364-376

159

1583

9761 Colcher A, Simuni T

Other Parkinson syndromes

NEUROLOGIC CLINICS. 2001 AUG; 19 (3): 629-+

159

1584

12422 Bayir H, Kochanek PM, Clark RSB

Traumatic brain injury in infants and children - Mechanisms of secondary damage and treatment in the intensive care unit

CRITICAL CARE CLINICS. 2003 JUL; 19 (3): 529-+

159

1585

14557 Ulloa-Aguirre A, Janovick JA, Brothers SP, Conn PM

Pharmacologic rescue of conformationally-defective proteins: Implications for the treatment of human disease

TRAFFIC. 2004 NOV; 5 (11): 821-837

127

159

1586

14651 Walter BL, Vitek JL

Surgical treatment for Parkinson's disease

LANCET NEUROLOGY. 2004 DEC; 3 (12): 719-728

159

1587

16496 Gong CX, Liu F, Grundke-Iqbal I, Iqbal K

Dysregulation of protein phosphorylation/dephosphorylation in Alzheimer's disease: A therapeutic target

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY. 2006; : Art. No. 31825

159

1588

17338 Hamaguchi T, Ono K, Yamada M

Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer's disease

CELLULAR AND MOLECULAR LIFE SCIENCES. 2006 JUL; 63 (13): 1538-1552

159

1589

19536 Curtis MA, Faull RLM, Eriksson PS

The effect of neurodegenerative diseases on the subventricular zone

NATURE REVIEWS NEUROSCIENCE. 2007 SEP; 8 (9): 712-723

159

1590

19740 Thomas B, Beal MF

Parkinson's disease

HUMAN MOLECULAR GENETICS. 2007 OCT 15; 16: R183-R194

148

159

Date / Author / Journal

LCS

GCS

LCR

1591

20049 Yankner BA, Lu T, Loerch P

The aging brain

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE. 2008; 3: 41-66

159

1592

21266 Tumani H, Teunissen C, Sossmuth S, Otto M, Ludolph AC, et al.

Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. 2008 JUL; 8 (4): 479-494

159

1593

21663 Aluise CD, Sowell RA, Butterfield DA

Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2008 OCT; 1782 (10): 549-558

159

1594

21697 Thal DR, Griffin WST, Braak H

Parenchymal and vascular A beta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2008 OCT; 12 (5B): 1848-1862

159

1595

22238 Koudinov A, Kezlya E, Koudinova N, Berezov T

Amyloid-beta, Tau Protein, and Oxidative Changes as a Physiological Compensatory Mechanism to Maintain CNS Plasticity under Alzheimer's Disease and Other Neurodegenerative Conditions

JOURNAL OF ALZHEIMERS DISEASE. 2009; 18 (2): 381-400

159

1596

22413 Blazer LL, Neubig RR

Small Molecule Protein-Protein Interaction Inhibitors as CNS Therapeutic Agents: Current Progress and Future Hurdles

NEUROPSYCHOPHARMACOLOGY. 2009 JAN; 34 (1): 126-141

159

1597

22863 Gispen-De Wied CC, Kritsidima M, Elferink AJA

The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES)

JOURNAL OF NUTRITION HEALTH & AGING. 2009 APR; 13 (4): 376-387

159

1598

23303 Leverenz JB, Quinn JF, Zabetian C, Zhang J, Montine KS, et al.

Cognitive Impairment and Dementia in Patients with Parkinson Disease

CURRENT TOPICS IN MEDICINAL CHEMISTRY. 2009 JUL; 9 (10): 903-912

159

1599

24529 Orlova KA, Crino PB

The tuberous sclerosis complex

YEAR IN NEUROLOGY 2. 2010; 1184: 87-105

159

1600

24990 Blennow K, Hampel H, Weiner M, Zetterberg H

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

NATURE REVIEWS NEUROLOGY. 2010 MAR; 6 (3): 131-144

159

Trojanowski w/citing papers Publications by JQ Trojanowski and the papers citing JQ Trojanowski	Historiographs	Glossary HistCite Guide About Grand Totals: LCS 336329, GCS 1007154, CR 1762209 Collection span: 1973 - 2011
List of All Records